ALOX5 and Sepsis: The complex interplay between AA-derived LMs in sepsis has also been highlighted in recent data showing that flavocoxid, a dual COX-2 and 5-LOX inhibitor, reduces the expression of NF-κB, COX-2, and 5-LOX with improved survival in a murine CLP model [40].